Global Active Pharmaceutical Ingredient(API) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Active Pharmaceutical Ingredient(API) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
Active Pharmaceutical Ingredient(API) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Active Pharmaceutical Ingredient(API) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oncology and Cardiology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Active Pharmaceutical Ingredient(API) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Active Pharmaceutical Ingredient(API) key manufacturers include Teva Pharmaceuticals, Pfizer, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Novartis, Mylan, Boehringer Ingelheim, Merck&Co. and AbbVie, etc. Teva Pharmaceuticals, Pfizer, Aurobindo Pharma are top 3 players and held % sales share in total in 2022.
Active Pharmaceutical Ingredient(API) can be divided into Generic API and Innovative API, etc. Generic API is the mainstream product in the market, accounting for % sales share globally in 2022.
Active Pharmaceutical Ingredient(API) is widely used in various fields, such as Oncology, Cardiology, Cns and Neurology and Orthopaedic, etc. Oncology provides greatest supports to the Active Pharmaceutical Ingredient(API) industry development. In 2022, global % sales of Active Pharmaceutical Ingredient(API) went into Oncology filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Active Pharmaceutical Ingredient(API) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Teva Pharmaceuticals
Pfizer
Aurobindo Pharma
Sun Pharmaceutical Industries Ltd.
Novartis
Mylan
Boehringer Ingelheim
Merck&Co.
AbbVie
Biocon
Bristol Myers Squibb
C.H.Boehringer Sohn AG&Co.KG
Cipla
Albemarle Corporation
Viatris
Dr. Reddy's Laboratories
Segment by Type
Generic API
Innovative API
Oncology
Cardiology
Cns and Neurology
Orthopaedic
Pulmonology
Gastroenterology
Nephrology
Ophthalmology
Endocrinology
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Active Pharmaceutical Ingredient(API) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Active Pharmaceutical Ingredient(API), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Active Pharmaceutical Ingredient(API) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Active Pharmaceutical Ingredient(API) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Active Pharmaceutical Ingredient(API) introduction, etc. Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Active Pharmaceutical Ingredient(API) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Active Pharmaceutical Ingredient(API) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Active Pharmaceutical Ingredient(API) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oncology and Cardiology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Active Pharmaceutical Ingredient(API) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Active Pharmaceutical Ingredient(API) key manufacturers include Teva Pharmaceuticals, Pfizer, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Novartis, Mylan, Boehringer Ingelheim, Merck&Co. and AbbVie, etc. Teva Pharmaceuticals, Pfizer, Aurobindo Pharma are top 3 players and held % sales share in total in 2022.
Active Pharmaceutical Ingredient(API) can be divided into Generic API and Innovative API, etc. Generic API is the mainstream product in the market, accounting for % sales share globally in 2022.
Active Pharmaceutical Ingredient(API) is widely used in various fields, such as Oncology, Cardiology, Cns and Neurology and Orthopaedic, etc. Oncology provides greatest supports to the Active Pharmaceutical Ingredient(API) industry development. In 2022, global % sales of Active Pharmaceutical Ingredient(API) went into Oncology filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Active Pharmaceutical Ingredient(API) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Teva Pharmaceuticals
Pfizer
Aurobindo Pharma
Sun Pharmaceutical Industries Ltd.
Novartis
Mylan
Boehringer Ingelheim
Merck&Co.
AbbVie
Biocon
Bristol Myers Squibb
C.H.Boehringer Sohn AG&Co.KG
Cipla
Albemarle Corporation
Viatris
Dr. Reddy's Laboratories
Segment by Type
Generic API
Innovative API
Segment by Application
Oncology
Cardiology
Cns and Neurology
Orthopaedic
Pulmonology
Gastroenterology
Nephrology
Ophthalmology
Endocrinology
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Active Pharmaceutical Ingredient(API) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Active Pharmaceutical Ingredient(API), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Active Pharmaceutical Ingredient(API) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Active Pharmaceutical Ingredient(API) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Active Pharmaceutical Ingredient(API) introduction, etc. Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Active Pharmaceutical Ingredient(API) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices